To synthesize current insights into the roles of immune populations within the tumor immune microenvironment (TIME) and their implications for NSCLC progression and immunotherapy, emphasizing their clinical significance.
Key Findings:
The TIME is crucial for NSCLC progression, immune evasion, and resistance to therapy, indicating a need for targeted interventions.
Tumor-associated macrophages (TAMs) exhibit plasticity, with a shift from M1 to M2 phenotypes during cancer progression, impacting therapeutic outcomes.
Tumor-associated neutrophils (TANs) can polarize into either anti-tumor or pro-tumor phenotypes, influencing tumor dynamics and treatment responses.
Interpretation:
Understanding the interactions within the TIME can inform the development of more effective immunotherapeutic strategies for NSCLC.
Limitations:
The review primarily focuses on immune cell types without extensive exploration of non-cellular components of the TIME, which may limit understanding of the full microenvironment.
Clinical implications and specific therapeutic strategies are not deeply analyzed, suggesting a gap for future research.
Conclusion:
The TIME plays a pivotal role in NSCLC, and targeting its components may enhance the efficacy of current therapies, underscoring the need for TIME-informed treatment strategies.
